LearnJune 28, 2026
Marketing a peptide brand under enforcement
Peptide brand marketing works best when it stays claim-safe. The FTC requires competent and reliable scientific evidence for health claims, and the FDA restricts several peptides in compounding. Build demand on owned channels and verifiable facts, not promises.
What does the FTC require before you make a health claim?
The FTC's Health Products Compliance Guidance, issued December 2022, replaced the 1998 dietary supplement advertising guide and covers foods, supplements, drugs, apps, and other health-related products. Its rule is direct: claims about health benefits or safety require substantiation in the form of competent and reliable scientific evidence.
For a benefit claim, that generally means randomized, controlled human clinical testing. The FTC weighs sample size, duration, and outcome measures. Animal and in vitro data alone do not qualify, and neither do consumer surveys. Write to the evidence you actually hold.
Which peptides carry FDA compounding restrictions?
The FDA maintains a Category 2 list of bulk drug substances that may present significant safety risks in compounding. Several peptides sit on or near it. For BPC-157, the FDA states compounded drugs may pose a risk for immunogenicity for certain routes of administration, with complexities around peptide-related impurities and active pharmaceutical ingredient characterization.
GHRP-2 for injectable and nasal routes was added in September 2023, cited for immunogenicity risk from aggregation and peptide-related impurities, plus an unnatural amino acid that complicates characterization. Know where each molecule you sell stands before you write a single line of copy about it.
How do you build demand without unsupported claims?
Lead with facts you can defend. Describe formulation, sourcing, testing, credentials, and process instead of promising outcomes you cannot substantiate. A precise, honest page converts a qualified reader better than a vague one that invites a warning letter.
Testimonials and expert endorsements carry the same burden as direct claims under the FTC guidance. If you could not substantiate a statement yourself, you cannot substantiate it through a customer or a paid expert. Screen every quote against that test.
- State the mechanism and evidence level plainly, including its limits
- Separate FDA-approved uses from research or wellness context
- Vet all endorsements against the direct-claim substantiation standard
- Keep a source file behind every factual statement on the page
Why do owned channels matter more here?
Ad platforms and payment processors apply their own health-claim policies on top of federal rules, and enforcement can remove your account without notice. A website, email list, and clinician relationships are assets you control and cannot lose to a policy change overnight.
Owned channels also let you publish the depth that regulated categories reward: sourcing detail, testing protocols, and clear scope-of-use language. That specificity is what a cautious buyer and a compliance reviewer both look for.
How do you earn AI and search visibility safely?
Answer engines and search both favor pages that state a named fact early and back it with a credible source. Structure each page to lead with a specific, verifiable statement, then support it. That format reads as trustworthy to a person and extractable to a model.
Cite primary sources such as FDA and FTC pages directly, and keep claims narrow enough to survive scrutiny. Practices that want booked appointments rather than marketing reports, the standard Rank and Rejuvenate works toward, tend to get there faster on verifiable copy than on aggressive language.
Sources
Common questions
Is BPC-157 legal to sell and market?
BPC-157 is not FDA-approved. The FDA has flagged compounded BPC-157 for immunogenicity risk on certain routes and for peptide impurity and characterization complexity. Its compounding status has shifted, so verify the current position before marketing it, and avoid treatment or outcome claims you cannot substantiate.
What counts as adequate substantiation for a peptide claim?
Under the FTC's 2022 guidance, health benefit claims generally need randomized, controlled human clinical testing, judged on sample size, duration, and outcome measures. Animal studies, in vitro data, and consumer surveys cannot carry a health claim on their own. Match each claim to the evidence you actually hold.
Do customer testimonials reduce my compliance risk?
No. The FTC treats testimonials and expert endorsements as carrying the same substantiation burden as claims you make directly. If you could not support a statement yourself with competent and reliable evidence, you cannot support it through a customer quote or a paid expert either.
Your schedule, predictable
Start with a free growth audit: your rankings, your reviews, your booking flow, and exactly where the patients are going instead. No contract. No pitch deck.